Skip to main content
ACOG ACSM 2023 Main banner
Back

ePoster

GYNECOLOGY

Elagolix With Add-Back Therapy Improves Hemoglobin Concentration in Women With Fibroid-Associated Heavy Menstrual Bleeding Across Subgroups: Post Hoc Analysis of Elaris UF-1 and UF-2 - F-08

Saturday, May 20, 2023
8:00 AM – 9:00 AM ET
Location: Hall D
Sub Topic: Evaluation/Diagnosis/Management of Gynecologic Conditions
  • SJ

    Susan Jewell, PhD

    Scientific Director
    AbbVie
    Long Grove, IL, U.S.

    Disclosure(s): AbbVie: Employee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)

Disclosure(s):
William D. Schlaff, MD: AbbVie: Consultant (Ongoing), University Grants/Research Support (Ongoing)
Susan Jewell, PhD: AbbVie: Employee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)